JPS5229318B2 - - Google Patents

Info

Publication number
JPS5229318B2
JPS5229318B2 JP47032033A JP3203372A JPS5229318B2 JP S5229318 B2 JPS5229318 B2 JP S5229318B2 JP 47032033 A JP47032033 A JP 47032033A JP 3203372 A JP3203372 A JP 3203372A JP S5229318 B2 JPS5229318 B2 JP S5229318B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP47032033A
Other languages
Japanese (ja)
Other versions
JPS4897898A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP47032033A priority Critical patent/JPS5229318B2/ja
Priority to US00343002A priority patent/US3850941A/en
Priority to CA166,899A priority patent/CA989843A/en
Priority to HUKI684A priority patent/HU167305B/hu
Priority to AU53761/73A priority patent/AU467607B2/en
Priority to SE7304464A priority patent/SE402592B/xx
Priority to BR732268A priority patent/BR7302268D0/pt
Priority to DE2315801A priority patent/DE2315801C3/de
Priority to GB1503773A priority patent/GB1378375A/en
Priority to FR7311419A priority patent/FR2182914B1/fr
Priority to AR247321A priority patent/AR197709A1/es
Priority to BE2052646A priority patent/BE797554A/xx
Priority to ES413188A priority patent/ES413188A1/es
Publication of JPS4897898A publication Critical patent/JPS4897898A/ja
Publication of JPS5229318B2 publication Critical patent/JPS5229318B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP47032033A 1972-03-30 1972-03-30 Expired JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP47032033A JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-30 1972-03-30
US00343002A US3850941A (en) 1972-03-30 1973-03-20 2-alkyl-3-acylpyrazolo(1,5-a)pyridines
CA166,899A CA989843A (en) 1972-03-30 1973-03-23 2-alkyl-3-acyl-pyrazolo(1,5-a) pyridines
HUKI684A HU167305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-30 1973-03-26
AU53761/73A AU467607B2 (en) 1973-03-26 Novel 2-alkyl-3-acyl-pyrazolo [1,5-a] pyridines
SE7304464A SE402592B (sv) 1972-03-30 1973-03-29 Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
BR732268A BR7302268D0 (pt) 1972-03-30 1973-03-29 Processo para obtencao de um derivado de 2-alquil-3-acil- pirazolo (1,5-a) piridina
DE2315801A DE2315801C3 (de) 1972-03-30 1973-03-29 2-Alkyl-3-acyl-pyrazolo [1,5-a] pyridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
GB1503773A GB1378375A (en) 1972-03-30 1973-03-29 Pyrazolopyridines processes for their preparation and compositions incorporating them
FR7311419A FR2182914B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-30 1973-03-29
AR247321A AR197709A1 (es) 1972-03-30 1973-03-30 Un procedimiento para la preparacion de un derivado de 2-aquil-3-acil-pirazolo(1,5-a) piridina
BE2052646A BE797554A (fr) 1972-03-30 1973-03-30 Nouvelles 2-alcoyl-3-acyl-pyrazolo (1,5-a)-pyridines repondant a la formule generale
ES413188A ES413188A1 (es) 1972-03-30 1973-03-30 Procedimiento para preparar un derivado de 2-alquil-3-acil-pirazol (1,5-a) piridina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47032033A JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-30 1972-03-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP8579476A Division JPS5214799A (en) 1976-07-19 1976-07-19 Process for preparing 2-alkyl-3-acyl- pyrazolo(1,5-a) pyridine derivat ives

Publications (2)

Publication Number Publication Date
JPS4897898A JPS4897898A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-13
JPS5229318B2 true JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-08-01

Family

ID=12347544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47032033A Expired JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-30 1972-03-30

Country Status (12)

Country Link
US (1) US3850941A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5229318B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR197709A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE797554A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR7302268D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA989843A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2315801C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES413188A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2182914B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1378375A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU167305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE402592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5968553A (ja) * 1982-10-13 1984-04-18 Automob Antipollut & Saf Res Center 燃料タンク内蔵式燃料ポンプ
JPS6072975U (ja) * 1983-10-26 1985-05-22 ヤンマーディーゼル株式会社 燃料ポンプのエア抜き装置
JPH0256853U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1989-10-04 1990-04-24
WO2009022740A1 (ja) 2007-08-15 2009-02-19 Kyorin Pharmaceutical Co., Ltd. イブジラストを有効成分とする脳動脈瘤の予防、形成抑制又は治療剤

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097483A (en) * 1974-11-01 1978-06-27 Kyorin Pharmaceutical Co., Ltd. Pyrazolo 1,5-a!pyridines
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
US4237300A (en) * 1975-12-09 1980-12-02 Merck & Co., Inc. Certain 6-substituted-2-pyridinamines
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 3―イソブチリル―2―イソプロピルピラゾロ〔1,5―a〕ピリジンの徐放性医薬品組成物
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
JPH01153633A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 経皮吸収製剤
EP0355234A1 (en) * 1988-08-25 1990-02-28 Merrell Dow Pharmaceuticals Inc. Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
JPH085790B2 (ja) * 1988-11-11 1996-01-24 杏林製薬株式会社 記憶障害改善薬
JPH06166687A (ja) * 1990-07-18 1994-06-14 Senju Pharmaceut Co Ltd ピラゾロ〔1,5−a〕ピリジン化合物、その製造法および用途
EA006685B1 (ru) 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
KR20110117731A (ko) 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 hmg―co 억제제로서의 이의 용도
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
DE602004031356D1 (de) 2003-11-21 2011-03-24 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
SG166829A1 (en) 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5352452B2 (ja) * 2006-06-06 2013-11-27 メディシノバ, インコーポレイテッド 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
PT2131841E (pt) 2007-01-30 2012-09-24 Univ Colorado Regents Métodos para tratar a dor aguda e sub-crónica
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7536799B2 (en) * 2007-06-07 2009-05-26 Keson Industries Chalk line apparatus with strategically located chalk fill opening
CA2692653A1 (en) * 2007-07-11 2009-01-15 Auckland Uniservices Limited Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy
WO2009023179A2 (en) * 2007-08-10 2009-02-19 Genelabs Technologies, Inc. Nitrogen containing bicyclic chemical entities for treating viral infections
WO2010005520A2 (en) * 2008-06-30 2010-01-14 Concert Pharmaceuticals, Inc. 2-alkyl-3-acylpyrazolo[1,5-a]pyridine derivatives
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2320907A4 (en) * 2008-08-05 2012-09-05 Merck Sharp & Dohme THERAPEUTIC COMPOUNDS
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
ES2525748T3 (es) 2009-11-13 2014-12-29 Toray Industries, Inc. Agente terapéutico o profiláctico para la diabetes
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2681236B1 (en) 2011-03-01 2018-01-03 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
ES2395801B1 (es) 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
CN102617579A (zh) * 2012-03-28 2012-08-01 黑龙江大学 一种异丁司特的制备方法
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN108033959A (zh) * 2018-01-29 2018-05-15 山东省药学科学院 一种异丁司特的化学合成方法
FI3911648T3 (fi) 2019-01-18 2025-01-10 Astrazeneca Ab 6'-[[[(1s,3s)-3-[[5-(difluorometoksi)-2-pyrimidinyyli]amino]syklopentyyli]amino][1(2h),3'-bipyridin]-2-oni pcsk9:n estäjänä ja menetelmät sen käyttöön
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合
CN113387947B (zh) * 2021-07-12 2022-07-01 中国科学院成都生物研究所 调节雌激素受体合成活性的吡唑并吡啶衍生物
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5968553A (ja) * 1982-10-13 1984-04-18 Automob Antipollut & Saf Res Center 燃料タンク内蔵式燃料ポンプ
JPS6072975U (ja) * 1983-10-26 1985-05-22 ヤンマーディーゼル株式会社 燃料ポンプのエア抜き装置
JPH0256853U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1989-10-04 1990-04-24
WO2009022740A1 (ja) 2007-08-15 2009-02-19 Kyorin Pharmaceutical Co., Ltd. イブジラストを有効成分とする脳動脈瘤の予防、形成抑制又は治療剤

Also Published As

Publication number Publication date
DE2315801B2 (de) 1978-06-22
GB1378375A (en) 1974-12-27
DE2315801C3 (de) 1979-02-22
DE2315801A1 (de) 1973-10-11
FR2182914B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-05-14
ES413188A1 (es) 1976-01-16
SE402592B (sv) 1978-07-10
FR2182914A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-14
JPS4897898A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-13
US3850941A (en) 1974-11-26
HU167305B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-27
AU5376173A (en) 1974-09-26
AR197709A1 (es) 1974-04-30
BR7302268D0 (pt) 1974-08-29
BE797554A (fr) 1973-07-16
CA989843A (en) 1976-05-25

Similar Documents

Publication Publication Date Title
FR2182914B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4996640A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS170479B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS171294B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS165869B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS170867B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS163865B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS175604B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS175590B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS153971B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS165488B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS176308B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CU33742A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS160804B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS158017B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS157431B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS157416B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS157367B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155029B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH566855A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH574892A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH577505A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH578348A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH578418A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH580114A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)